Venture&Growth
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Ablative Solutions is a medical device company that has developed a best-in-class drug delivery catheter, the Peregrine SystemTM, which delivers a neurolytic agent to the adventitia of the renal arteries for the purposes of ablating the surrounding nerves.
This procedure, known as renal denervation, has a potentially significant effect in the treatment of hypertension.
The Ablative Solutions procedure is quick, relatively painless and results in deep, circumferential ablation of the renal nerves.
The company has CE Mark and is currently engaged in clinical studies in Europe and the United States.
More Ablative Solutions news
Ablative Solutions Announces Positive 12-Month Results from Study Evaluating Company’s Novel Therapy for Uncontrolled Hypertension
Ablative Solutions Announces Appointment of Kate Rumrill as President and Chief Executive Officer
Vapotherm
Vapotherm is a worldwide, commercial company that develops, manufactures and sells Precision Flow, a high-velocity...

Ablative Solutions
Ablative Solutions is a medical device company that has developed a best-in-class drug delivery catheter,...

Acacia Pharma
Acacia Pharma is a revenue stage biopharmaceutical company focused on developing and commercializing novel products...
